DANIEL MOLLOY, MD MENTOR: JAMES STEPHEN, MD
|
|
- Dina Lee
- 5 years ago
- Views:
Transcription
1 Blood Glucose Control in a Schizophrenic Population in an Outpatient Setting DANIEL MOLLOY, MD MENTOR: JAMES STEPHEN, MD
2 Schizophrenia Complex psychiatric disorder with many medical and psychosocial complications. Characterized by a heterogeneous mixture of clinical features psychosis (1). Incidence: 10 to 40 / 100,000 population High risk for poverty, unemployment, homelessness or inadequate housing, ill health, and poor access to health care(1). Meltzer H.Y., Bobo W.V., Heckers S.H., Fatemi H.S. (2008). Chapter 16. Schizophrenia. In M.H. Ebert, P.T. Loosen, B. Nurcombe, J.F. Leckman (Eds), CURRENT Diagnosis & Treatment: Psychiatry, 2e.
3 Background Per DSM IV TR (2), to diagnose schizophrenia, a patient must have at least 2 of the following: Delusions Hallucinations Disorganized speech and/or Disorganized behavior, Negative symptoms (alogia, avolition, and flat affect). These must be at least 6 months in duration and produce disturbances in work, self-care, and interpersonal relations. American Psychiatric Association. DSM-IV. Diagnostic and statistical manual of mental disorders. 4th ed. Washington: American Psychiatric Association, 1994:
4 Background Associated medical issues(3): 20% decreased life expectancy Increased rates of cardiovascular and metabolic abnormalities. Overall poorer health related quality of life. McGrath J, Saha S, Welham J, El Saadi O, Macauley C, Chant D. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med. 2:13 (2004).
5 Background Prevalence of type 2 diabetes in schizophrenic populations can be 2 4 times higher than in the general population, 15 18%(4). The exact reason in unclear, but likely to include Poor diet Sedentary lifestyle Substance abuse Family association - monozygotic twins/1 st degree relatives Schizophrenia and Diabetes 2003 Expert Consensus Meeting, Dublin, 3 4 October 2003: consensus summary, The British Journal of Psychiatry (2004) 184: s112-s114.
6 Hemoglobin A1c Formed by the irreversible, nonenzymatic binding of glucose to the terminal end of the beta chain of hemoglobin Serves as a predictable measure of average blood glucose over period of days. ADA Clinical Practice Recommendations now recommend using HbA1c to diagnose diabetes using a NGSP-certified method and a cutoff of HbA1c 6.5%(5). Diabetes Care January 2012 vol. 35 no. Supplement 1 S11-S63
7 Hemoglobin A1c Certain limitations to hemoglobin A1c are known: Dependent on lifespan of RBC Influenced by hemoglobin variety Laboratory dependent standardization
8 Antipsychotic medications Antipsychotic medications commonly used in the treatment of schizophrenia have a well documented tendency to cause hyperglycemia and/or insulin resistance (6). Particularly pronounced in patients receiving certain members of the class of second generation antipsychotics(6). Cause is not entirely elucidated Gautam, S., and PS Meena. "Drug-emergent Metabolic Syndrome in Patients with Schizophrenia Receiving Atypical (second-generation) Antipsychotics." Indian Journal of Psychiatry 53.2 (2011):
9 Rationale Quality outcome measurements are becoming an increasingly important aspect of day to day practice.
10 Rationale Bias towards mentally ill patients influences healthcare provider decision making (4). One study with standardized patient showed HCP less likely to prescribe appropriate therapies/medications to schizophrenic patients(4). Also includes mental health professionals (4). Mittal, Dinesh, MD. "Does Serious Mental Illness Influence Treatment Decisions of Physicians and Nurses?" Lecture. American Psychiatric Assocation 2012 Annual Meeting. San Francisco. 20 May APA 166th Meeting. American Psychiatric Association, May 2013
11 Aims Primary Objective: To determine whether a difference in average blood glucose control exists between a schizophrenic and a non - schizophrenic population in an outpatient setting.
12 Aims Secondary Objectives: To determine whether an association exists between A1c levels and the number of healthcare contact events during study period. To assess the prevalence of vascular disease between schizophrenic and non schizophrenic patients.
13 Methods Retrospective case control study IRB approval obtained prior to study commencement Data collected over a one year period from April 2012 to April 2013 Chart based; information obtained from EMR
14 Methods Inclusion criteria: Diagnosis of Schizophrenia Treated in outpatient setting At least one hemoglobin A1c obtained within the study period
15 Methods Exclusion criteria: End stage renal disease Hemolytic anemia/ hemoglobinopathy No hemoglobin A1c within study period
16 Methods 245 Schizophrenic patients identified. 72 diagnoses of Diabetes mellitus. 7 excluded due to exclusion criteria Total of 65 patients included
17 Methods A control cohort of 65 randomly sampled diabetic patients was recruited based on several matching variables: Age Race Gender.
18 Variables Age Gender Race BMI LDL level Triglyceride level HDL level Smoking status Number of clinic visits during study period Medications for schizophrenia Use of Insulin therapy Anemia Kidney disease Vascular complications
19 Statistical Analysis ANCOVA, t-tests, chi-square (χ 2 ) tests as appropriate. SPSS software (SPSS Inc, Chicago, Illinois) was used for data analysis. P<0.05 was considered significant
20 Variable Schizophrenic Nonschizophrenic p-value Age Gender M 28 F 37 Race Caucasian 36 AA 22 Hisp 6 M 30 F 35 Caucasian 38 AA 22 Hisp A1c Number of Clinic visits Smoking Y 29 N 36 Y 20 N Kidney Disease Y 10 N 55 Y 10 N 55 N/A
21 Variable Schizophrenic Nonschizophrenic p-value Mean Age Gender M 28 F 37 Race Caucasian 36 AA 22 Hisp 6 M 30 F 35 Caucasian 38 AA 22 Hisp A1c Number of Clinic visits Smoker Y 29 N 36 Y 20 N Kidney Disease Y 10 N 55 Y 10 N 55 N/A
22 Variable Schizophrenic Nonschizophrenic P-value LDL HDL Triglycerides Anemia Yes 15 N o 50 Yes 10 No BMI Diabetes treatment Insulin 16 Oral 43 Diet 6 Insulin 36 Oral 25 Diet (without insulin)
23 Schizophrenia and diabetes associated vascular complications Schizophrenia P-value Yes No Vascular complications Yes 6 22 No Vascular complications defined as coronary artery disease, peripheral vascular disease, and cerebrovascular disease
24 Hemoglobin A1c in Schizophrenic patients treated with typical vs Atypical Antipsychotics Typical Atypical Other p-value Number of Schizophrenics A1c
25 No. Variable P value 1 Age Gender Race Smoking status Anemia Number of clinic visits BMI Schizophrenia 0.001
26 Limitations of Study Retrospective Chart based Multiple providers participating in patient care
27 Conclusions 1. There was a significant difference in the hemoglobin A1c between patients with schizophrenia {mean A1c 6.6, SD =1.3} and without schizophrenia {mean A1c 8.4, SD =2.6} after controlling the effect of age, race, gender, BMI, anemia and number of clinic visits (p <0.001).
28 Conclusions 2. There was a significant difference in the prevalence of vascular diseases between patients with schizophrenia {9.2%} and without schizophrenia {33.8%} after controlling the effect of age, race, gender, BMI, anemia and number of clinic visits (p <0.001).
29 Conclusions 3. There was no significant difference in the hemoglobin A1c between schizophrenic patients taking atypical antipsychotics {mean A1c 6.9, SD =1.1} and patients taking typical antipsychotics{ mean A1c =6.4, SD = 1.6} (p<0.323).
30 Conclusion/Discussion A diagnosis of schizophrenia does not mean that a patient is incapable of managing their medical conditions. Caretakers must be careful to avoid letting bias influence their decision making. Further prospective study may uncover reasons for this difference.
31 Acknowledgements Srikrishna Varun Malayala, MBBS Khalid J Qazi, MD, MACP Henri Woodman, MD Nikhil Satchidanand, PhD
32 Thank You
Moving to an A1C-Based Screening & Diagnosis of Diabetes. By Prof.M.Assy Diabetes&Endocrinology unit
Moving to an A1C-Based Screening & Diagnosis of Diabetes By Prof.M.Assy Diabetes&Endocrinology unit is the nonenzymatic glycated product of the hemoglobin beta-chain at the valine terminal residue. Clin
More informationSCIENTIFIC STUDY REPORT
PAGE 1 18-NOV-2016 SCIENTIFIC STUDY REPORT Study Title: Real-Life Effectiveness and Care Patterns of Diabetes Management The RECAP-DM Study 1 EXECUTIVE SUMMARY Introduction: Despite the well-established
More information8/22/2016. Contemporary Psychiatric-Mental Health Nursing Third Edition. Features of Schizophrenia. Features of Schizophrenia (cont'd)
Contemporary Psychiatric-Mental Health Nursing Third Edition CHAPTER 16 Schizophrenia Features of Schizophrenia Prevalence in U.S. is 1.1%. Average onset is late teens to early twenties, but can be as
More informationMore than We Bargained For: Metabolic Side Effects of Antipsychotic Medications
More than We Bargained For: Metabolic Side Effects of Antipsychotic Medications Michael D. Jibson, MD, PhD Professor of Psychiatry University of Michigan Disclosure In the past 12 months I have received
More informationContemporary Psychiatric-Mental Health Nursing. Features of Schizophrenia. Features of Schizophrenia - continued
Contemporary Psychiatric-Mental Health Nursing Chapter 16 Schizophrenia and Other Psychotic Disorders Features of Schizophrenia Prevalence in U.S. is 1.1%. Average onset is late teens to early twenties,
More informationMetabolic Monitoring, Schizophrenia Spectrum Illnesses, & Second Generation Antipsychotics
Metabolic Monitoring, Schizophrenia Spectrum Illnesses, & Second Generation Antipsychotics National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State Office of Mental
More informationResults. NeuRA Worldwide incidence April 2016
Introduction The incidence of schizophrenia refers to how many new cases there are per population in a specified time period. It is different from prevalence, which refers to how many existing cases there
More informationMedical and Mental Health Integration; Diabetes and Depression Care. Mercy Moto MSN, DNP-c DNP Project April, 2018 Chair: Dr.
Medical and Mental Health Integration; Diabetes and Depression Care Mercy Moto MSN, DNP-c DNP Project April, 2018 Chair: Dr. Moore PICO Question What is the impact of BHT on Type 2 diabetic mellitus (T2DM)
More informationAPNA 27th Annual Conference Session 2036: October 10, 2013
Leigh Powers DNP, MSN, MS, BS, APRN, PMHNP BC APNA Annual Conference October 10, 2013 *The speaker has no conflicts of interest to disclose Compare quality of care through measurement of adherence to a
More informationSevere Mental Disorders. Etheldreda Nakimuli-Mpungu, MMed (Psych), MBChB Johns Hopkins University
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More informationIs Lurasidone more safe and effective in the treatment ofschizoaffective disorder and schizophrenia than other commonanti-psychotic medications?
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2015 Is Lurasidone more safe and effective
More information9/3/2014. Contemporary Psychiatric-Mental Health Nursing Third Edition. Features of Schizophrenia. Features of Schizophrenia (cont'd)
Contemporary Psychiatric-Mental Health Nursing Third Edition CHAPTER 16 Schizophrenia Features of Schizophrenia Prevalence in U.S. is 1.1%. Average onset is late teens to early twenties, but can be as
More informationSchizophrenia. Brooke Jones Charity Payne Alyssa Stewart
Schizophrenia Brooke Jones Charity Payne Alyssa Stewart Brogan s Story Definition Schizophrenia is a severe mental disorder in which people interpret reality abnormally. Schizophrenia may result in some
More informationIs Aristada (Aripiprazole Lauroxil) a Safe and Effective Treatment For Schizophrenia In Adult Patients?
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 12-2016 Is Aristada (Aripiprazole Lauroxil)
More information4. General overview Definition
4. General overview 4.1. Definition Schizophrenia is a severe psychotic mental disorder characterized by significant disturbances of mental functioning. It has also been called early dementia, intrapsychic
More informationNovember 2014 MRC2.CORP.X.00004
This program is paid for by Otsuka America Pharmaceutical, Inc. and Lundbeck, LLC. The speaker is a paid consultant of Otsuka America Pharmaceutical, Inc. advice or professional diagnosis. Users seeking
More informationHBA1C AS A MARKER FOR HIGH RISK DIABETIC SURGICAL PATIENT
Basrah Journal Of Surgery Bas J Surg, September, 18, 2012 HBA1C AS A MARKER FOR HIGH RISK DIABETIC SURGICAL PATIENT MB,ChB, DA, FICMS, Lecturer in Anesthesiology, Department of Surgery, College of Medicine,
More informationSupplementary Online Content
Supplementary Online Content Larsen JR, Vedtofte L, Jakobsen MSL, et al. Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine- or olanzapine-treated patients with schizophrenia
More informationNuplazid. Nuplazid (pimavanserin) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.60.03 Subject: Nuplazid Page: 1 of 4 Last Review Date: June 22, 2018 Nuplazid Description Nuplazid (pimavanserin)
More informationEARLY ONSET SCHIZOPHRENIA
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences EARLY ONSET SCHIZOPHRENIA JON MCCLELLAN CHILD STUDY AND TREATMENT CENTER GENERAL DISCLOSURES The University of Washington
More informationChapter 12. Schizophrenia and Other Psychotic Disorders. PSY 440: Abnormal Psychology. Rick Grieve Western Kentucky University
Chapter 12 Schizophrenia and Other Psychotic Disorders PSY 440: Abnormal Psychology Rick Grieve Western Kentucky University psychotic disorders disorders so severe that the person has essentially lost
More informationReduced 10-year Risk of CHD in Patients who Participated in Communitybased DPP: The DEPLOY Pilot Study
Diabetes Care Publish Ahead of Print, published online December 23, 2008 Reduced 10-year CHD Risk: DEPLOY Pilot Study Reduced 10-year Risk of CHD in Patients who Participated in Communitybased DPP: The
More informationMichael J. Bailey, M.D. OptumHealth Public Sector
Michael J. Bailey, M.D. OptumHealth Public Sector LIHP Quality Charter To ensure the quality of care delivered to enrollees in San Diego County Assistance Programs, such as County Medical Services (CMS)
More informationBy Jason H. King DECONSTRUCTING THE DSM-5 ASSESSMENT AND DIAGNOSIS OF SCHIZOPHRENIA SPECTRUM DISORDERS THE NEW LANDSCAPE
DECONSTRUCTING THE DSM-5 By Jason H. King ASSESSMENT AND DIAGNOSIS OF SCHIZOPHRENIA SPECTRUM DISORDERS Happy New Year as you engage in your counseling, research, supervision or educational endeavors. I
More informationSuboptimal Response in Psychotic & Mood Disorders: Causes, Consequences, and Management Strategies
Suboptimal Response in Psychotic & Mood Disorders: Causes, Consequences, and Management Strategies Henry A. Nasrallah, MD Sydney W. Souers Professor and Chair, Department of Psychiatry, Saint Louis University,
More informationPage # 1. Objectives. History of Clinical Trials. Developing New Therapies Clinical Studies and Trials. FDA Classification of Clinical Studies/Trials
Developing New Therapies Clinical Studies and Trials Richard C. Eastman M.D. Objectives Discuss how new treatments are studied in humans. Explain how the rights of human volunteers are safeguarded. Discuss
More informationPredictors of Severity of Alcohol Withdrawal in Hospitalized Patients
Elmer Original Article ress Predictors of Severity of Alcohol Withdrawal in Hospitalized Patients Radhames Ramos a, Thierry Mallet b, Anthony DiVittis c b, d, e, Ronny Cohen Abstract Background: Alcohol
More informationSchizophrenia and Other Psychotic Disorders
Schizophrenia and Other Psychotic Disorders Chapter 14 This multimedia product and its contents are protected under copyright law. The following are prohibited by law: any public performance or display,
More informationMERSEY CARE NHS TRUST HOW WE MANAGE MEDICINES. MM11 - High-Dose Antipsychotic Use Guidelines (local guideline) KEY ISSUES
MERSEY CARE NHS TRUST HOW WE MANAGE MEDICINES MM11 - High-Dose Antipsychotic Use Guidelines (local guideline) Medicines Management Services aim to ensure that (i) Service users receive their medicines
More informationThe psychological disorders
The psychological disorders Defining abnormal Statistical infrequency Normal distribution; the normal curve Violation of norms Culture bound syndromes Personal distress Some disorders do not involve distress
More informationSupplementary Online Content
Supplementary Online Content Subotnik KL, Casaus LR, Ventura J, et al. Long-acting injectable risperidone for relapse prevention and control of breakthrough symptoms after a recent first episode of schizophrenia:
More informationSevere Mental Illness and Diabetes. Charlie Place
Severe Mental Illness and Diabetes Charlie Place Intro Me Community Mental Health Nurse Case manager for Assertive Outreach Team in Leeds Severe Mental Illness (SMI) usually diagnosis of schizophrenia
More informationPlasma fibrinogen level, BMI and lipid profile in type 2 diabetes mellitus with hypertension
World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original
More informationPsychological Disorders
Chapter 12 Psychological 12-1 Abnormal Behavior The most commonly used criteria for distinguishing between normal and abnormal behaviors are: 12-2 Abnormal Behavior We can define behaviors as abnormal
More informationEffect of family intervention on functioning among patients with chronic schizophrenia
Original article Sreeja, I: Effect of family intervention on functioning Effect of family intervention on functioning among patients with chronic schizophrenia Sreeja I Email: sreeja009@rediffmail.com
More informationPsychosocial Issues for People with Diabetes. Richard Arakaki, M.D. Phoenix Area Diabetes Consultant June 28, 2017
Psychosocial Issues for People with Diabetes Richard Arakaki, M.D. Phoenix Area Diabetes Consultant June 28, 2017 Objectives Provide epidemiological and interventional data of DM in AI/AN and general population
More informationIdentifying the comorbid conditions affecting Hemoglobin A1c levels of diabetes among African American population
Identifying the comorbid conditions affecting Hemoglobin A1c levels of diabetes among African American population Fakhrudin A. Mohamed, MD; Jason Kushner, MD, MS; Junita Jose (MSY3); Stephanie C. Clerge,
More informationSponsor Novartis. Generic Drug Name Vildagliptin/Metformin. Therapeutic Area of Trial Type 2 diabetes. Approved Indication Type 2 diabetes
Clinical Trial Results Database Page 1 Sponsor Novartis Generic Drug Name Vildagliptin/Metformin Therapeutic Area of Trial Type 2 diabetes Approved Indication Type 2 diabetes Study Number CLMF237A2309
More informationDIMENSIONS: Well Body Toolkit for Healthcare Providers
Behavioral Health & Wellness Program University of Colorado Anschutz Medical Campus School of Medicine DIMENSIONS: Well Body Toolkit for Healthcare Providers SUPPLEMENT Behavioral Health & Wellness Program
More informationDOWNLOAD OR READ : TREATMENT OF SCHIZOPHRENIA FAMILY ASSESSMENT AND INTERVENTION PDF EBOOK EPUB MOBI
DOWNLOAD OR READ : TREATMENT OF SCHIZOPHRENIA FAMILY ASSESSMENT AND INTERVENTION PDF EBOOK EPUB MOBI Page 1 Page 2 treatment of schizophrenia family assessment and intervention treatment of schizophrenia
More informationATTENTION-DEFICIT/HYPERACTIVITY DISORDER, PHYSICAL HEALTH, AND LIFESTYLE IN OLDER ADULTS
CHAPTER 5 ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, PHYSICAL HEALTH, AND LIFESTYLE IN OLDER ADULTS J. AM. GERIATR. SOC. 2013;61(6):882 887 DOI: 10.1111/JGS.12261 61 ATTENTION-DEFICIT/HYPERACTIVITY DISORDER,
More informationThe Brain and the Body: Medical Comorbidities in Psychiatric Illness. Kate Miley, CNP Psychiatric Nurse Practitioner, HCMC Adult Psychiatry Clinic
The Brain and the Body: Medical Comorbidities in Psychiatric Illness Kate Miley, CNP Psychiatric Nurse Practitioner, HCMC Adult Psychiatry Clinic The Problem: Health Disparities in SMI Life expectancy
More informationEffectiveness of a Multidisciplinary Patient Assistance Program in Diabetes Care
University of Rhode Island DigitalCommons@URI Senior Honors Projects Honors Program at the University of Rhode Island 2009 Effectiveness of a Multidisciplinary Patient Assistance Program in Diabetes Care
More informationCardiovascular health monitoring in patients with psychotic illnesses: A project to investigate and improve performance in primary and secondary care
BMJ Quality Improvement Reports 2013; 2, No. 1 u632.w640 doi: 10.1136/bmjquality.u632.w640 Cardiovascular health monitoring in patients with psychotic illnesses: A project to investigate and improve performance
More informationDiabetes Prevention. Preventing Diabetes -- On AAA Home, the hyperlink beside the LESS Initiative hyperlink.
Diabetes Prevention Preventing Diabetes -- On AAA Home, the hyperlink beside the LESS Initiative hyperlink. Preventing Diabetes is the extension of the LESS Initiative and should be completed as part of
More informationCondensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia
Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia I. Key Points a. Schizophrenia is a chronic illness affecting all aspects of person s life i. Treatment Planning Goals 1.
More informationComparison of pre-treatment clinical characteristics and post-treatment outcomes of patients treated with Clozapine and long acting antipsychotics
Research Comparison of pre-treatment clinical characteristics and post-treatment outcomes of patients treated with Dante M Durand,1, Phillip Harvey 1,2, Ricardo Cáceda 3 ABSTRACT Introduction: Clozapine
More informationMeasure Owner Designation. AMA-PCPI is the measure owner. NCQA is the measure owner. QIP/CMS is the measure owner. AMA-NCQA is the measure owner
2011 EHR Measure Specifications The specifications listed in this document have been updated to reflect clinical practice guidelines and applicable health informatics standards that are the most current
More informationSchizophrenia: Treating The Whole Person
Schizophrenia: Treating The Whole Person Jacob S. Ballon, M.D., M.P.H & Douglas L. Noordsy, M.D. INSPIRE Clinic PEPPNET Prodrome and Early Psychosis Program NETwork Stanford University Department of Psychiatry
More informationWelcome and Introduction
Welcome and Introduction This presentation will: Define obesity, prediabetes, and diabetes Discuss the diagnoses and management of obesity, prediabetes, and diabetes Explain the early risk factors for
More informationClinical Practice Guidelines for Diabetes Management
Clinical Practice Guidelines for Diabetes Management Diabetes is a disease in which blood glucose levels are above normal. Over the years, high blood glucose damages nerves and blood vessels, which can
More informationOrientation to Mental Health - Student Assignment
Orientation to Mental Health - Student Assignment This is an example structure of a case study assignment given by the Practice Educator whilst on placement. ABOUT THIS SERVICE 1. Describe the role of
More informationEarly Stages of Psychosis. Learning Objectives
Early Stages of Psychosis Stephan Heckers, MD MSc Department of Psychiatry and Behavioral Sciences Vanderbilt University Learning Objectives Summarize the five domains of psychosis Describe how psychotic
More informationDiabetes Passport. East Coast Area Diabetes Integrated Care
Diabetes Passport East Coast Area Diabetes Integrated Care Personal Details Name: Address: Developed by East Coast Area Diabetes Programme (ECAD), 2014. Thanks to Beaumont Hospital for allowing us to use
More informationSchizophrenia. Nikita Verma 2017 Page 1
Schizophrenia It is a severe psychiatric disorder with symptoms of emotional instability, detachment from reality and withdrawal into self. It is an umbrella term used to outline a range of different psychiatric
More informationPsychosis, Mood, and Personality: A Clinical Perspective
Psychosis, Mood, and Personality: A Clinical Perspective John R. Chamberlain, M.D. Assistant Director, Psychiatry and the Law Program Assistant Clinical Professor University of California San Francisco
More informationCommunity Services - Eligibility
Community Services - Eligibility In order for DMH to reimburse care, the individual must meet both financial and clinical eligibility criteria. These criteria are described in detail in the DMH provider
More informationSupplementary Methods
Supplementary Materials for Suicidal Behavior During Lithium and Valproate Medication: A Withinindividual Eight Year Prospective Study of 50,000 Patients With Bipolar Disorder Supplementary Methods We
More informationClinical Guidelines for the Pharmacologic Treatment of Schizophrenia
Clinical Guidelines for the Pharmacologic Treatment of Community Behavioral Health (CBH) is committed to working with our provider partners to continuously improve the quality of behavioral healthcare
More informationSupplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms
Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms QQ QR/RR n = 36 n = 80 Men (%) 20 (55) 54 (67) 0.216 Age (years) 57 ± 10 56 ±
More informationPsychotic Disorders. Schizophrenia. Age Distribution of Onset 2/24/2009. Schizophrenia. Hallmark trait is psychosis
Psychotic Disorders Schizophrenia Schizophrenia Affects people from all walks of life Is about as prevalent as epilepsy Usually begins in late adolescence or early adulthood Hallmark trait is psychosis
More informationDYSLIPIDAEMIC PATTERN OF PATIENTS WITH TYPE 2 DIABETES MELLITUS. Eid Mohamed, Mafauzy Mohamed*, Faridah Abdul Rashid
Malaysian Journal of Medical Sciences, Vol. 11, No. 1, January 2004 (44-51) ORIGINAL ARTICLE DYSLIPIDAEMIC PATTERN OF PATIENTS WITH TYPE 2 DIABETES MELLITUS Eid Mohamed, Mafauzy Mohamed*, Faridah Abdul
More informationDESIGN TYPE AND LEVEL OF EVIDENCE: Randomized controlled trial, Level I
CRITICALLY APPRAISED PAPER (CAP) Hasan, A. A., Callaghan, P., & Lymn, J. S. (2015). Evaluation of the impact of a psychoeducational intervention for people diagnosed with schizophrenia and their primary
More informationE LeAP STUDY ECHOCARDIOGRAPHIC LEFT ATRIAL PRESSURE: COMPARATIVE REVIEW IN PATIENTS WITH SINUS RHYTHM AND ATRIAL FIBRILLATION
E LeAP STUDY ECHOCARDIOGRAPHIC LEFT ATRIAL PRESSURE: COMPARATIVE REVIEW IN PATIENTS WITH SINUS RHYTHM AND ATRIAL FIBRILLATION Moghniuddin Mohammed, M.B.B.S. Mentor: Dr. Harry McCrea, M.D. Dr. Yuji Saito,
More informationSchizophrenia. Class Objectives. Can someone be psychotic without having schizophrenia? 12/7/2011. Other psychotic disorders and causes
Schizophrenia Other psychotic disorders and causes Class Objectives What are Delusional Disorders? What causes Schizophrenia? How can Schizophrenia be treated? Can someone be psychotic without having schizophrenia?
More informationPractical Psychopharmacology for More Complex Mental Health Presentations
MINISTRY OF CHILDREN AND YOUTH SERVICES Practical Psychopharmacology for More Complex Mental Health Presentations Part 2: Antipsychotics & Mood Stabilizers Dr. Ajit Ninan & Joel Lamoure 1 : Who are we?
More informationEpidemiology of Psychosis
Epidemiology of Psychosis Chris Gale Otago Registrar Training Group Feb 2011. Methodologies used. Population surveys. General population. High risk populations. Screener and re-interview. Case records
More informationA Summary Report: 2003
D iabetes in Idaho A Summary Report: 2003 Idaho Department of Health and Welfare Division of Health Bureau of Community and Environmental Health This publication was supported by Grant No. U32/CCU022691-02
More informationClass Update: Oral Antipsychotics
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationFinancial Disclosure. Learning Objectives. Evaluation of Chemotherapy in Last 2 Weeks of Life: CAMC Patterns of Care
Evaluation of Chemotherapy in Last 2 Weeks of Life: CAMC Patterns of Care Steven J. Jubelirer, MD Clinical Professor Medicine WVU Charleston Division Senior Research Scientist CAMC Research Institute Charleston
More informationTable 2. Distribution of Normalized Inverse Probability of Treatment Weights. Healthcare costs (US $2012) Notes:
228 COMPARISON OF HEALTHCARE RESOURCE UTILIZATION AND MEDICAID SPENDING AMONG PATIENTS WITH SCHIZOPHRENIA TREATED WITH ONCE MONTHLY PALIPERIDONE PALMITATE OR ORAL ATYPICAL ANTIPSYCHOTICS USING THE INVERSE
More informationDisclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease
Disclosures Diabetes and Cardiovascular Risk Management Tony Hampton, MD, MBA Medical Director Advocate Aurora Operating System Advocate Aurora Healthcare Downers Grove, IL No conflicts or disclosures
More informationImpact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients
2012 International Conference on Life Science and Engineering IPCBEE vol.45 (2012) (2012) IACSIT Press, Singapore DOI: 10.7763/IPCBEE. 2012. V45. 14 Impact of Physical Activity on Metabolic Change in Type
More informationSchizophrenia FAHAD ALOSAIMI
Schizophrenia FAHAD ALOSAIMI MBBS, SSC - PSYCH C ONSULTATION LIAISON PSYCHIATRIST K ING SAUD UNIVERSITY Schizophrenia - It is not a single disease but a group of disorders with heterogeneous etiologies.
More informationPatient is healthy with no chronic disease or significant risk factors [16%].
AAFP Risk Level 1 Patient is healthy with no chronic disease or significant risk factors [16%]. Exclude the following chronic problems from active patient list o Depression o Diabetes Type I or Type II
More informationRe: Safety data on Zyprexa (olanzapine) and Symbyax (olanzapine and fluoxetine HCl capsules) Hyperglycemia, Weight Gain, and Hyperlipidemia
www.lilly.com Eli Lilly and Company Lilly Corporate Center Indianapolis, Indiana 46285 U.S.A. Phone 317 276 2000 October 5, 2007 Re: Safety data on Zyprexa (olanzapine) and Symbyax (olanzapine and fluoxetine
More informationJanice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES
Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES Objectives u At conclusion of the lecture the participant will be able to: 1. Differentiate between the classifications of diabetes
More informationLab Values Explained. working at full strength. Other possible causes of an elevated BUN include dehydration and heart failure.
Patient Education Lab Values Explained Common Tests to Help Diagnose Kidney Disease Lab work, urine samples and other tests may be given as you undergo diagnosis and treatment for renal failure. The test
More informationUse of Psychotherapeutic Medications in Children and Adolescents with ASD and ID
Use of Psychotherapeutic Medications in Children and Adolescents with ASD and ID Although not considered first line treatment in children with ASD and ID, depending on the severity of symptoms, some medications
More informationSupplementary Online Content
Supplementary Online Content Leibowitz M, Karpati T, Cohen-Stavi CJ, et al. Association between achieved low-density lipoprotein levels and major adverse cardiac events in patients with stable ischemic
More informationAccurate Diagnosis of Primary Psychotic Disorders
Accurate Diagnosis of Primary Psychotic Disorders The Care Transitions Network National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State Office of Mental Health Netsmart
More informationTracey G. Skale, MD Chief Medical Officer Greater Cincinnati Behavioral Health
Schizophrenia: What Do We Know? Where Do We Go From Here? Tracey G. Skale, MD Chief Medical Officer Greater Cincinnati Behavioral Health Objectives Participants will be able to: Understand the clinical
More informationTrue or False? Chapter 14 Psychological Disorders. What is Abnormal Behavior? 12/9/10. Characteristics of Abnormal Behavior
Chapter 14 Psychological Disorders Defining Abnormality Classifying Psychological Disorders Origins of Psychological Disorders True or False? Abnormal behaviors are always bizarre. A clear distinction
More informationADHD and Adverse Health Outcomes in Adults
Thomas J. Spencer, MD This work was supported in part by a research grant from Shire (Dr. Spencer) and by the Pediatric Psychopharmacology Council Fund. Disclosures Dr. Spencer receives research support
More informationEMDR and Severe Mental Disorders
EMDR and Severe Mental Disorders Reflections on the concept of therapeutic resistance Anabel Gonzalez MD, PhD. anabelgonzalez@outlook.com Resistant patients or inadequate models? Severe Mental Illness
More informationSchizophrenia as a disorder of thought, or language? Evidence from brain and behavioral investigations
Schizophrenia as a disorder of thought, or language? Evidence from brain and behavioral investigations Karen Froud Teachers College, Columbia University New York City Outline Big questions, and why this
More information4.Do a Mini Mental State Examination on your study buddy.
MCQ PYCHIATRIC DIORDER UAN TUCKER 1.High yield indicators of an organic illness include all of these except? a) disorientation b) rapid onset c) no pre morbid decline d) a score of 23 on Folsteins Mini
More informationMary Schepler
Mary Schepler Mary.Schepler@thresholds.org WHAT WORDS OR PHRASES HAVE YOU HEARD ASSOCIATED WITH MENTAL ILLNESS? People with mental illness frighten and embarrass us and so we marginalize people who most
More informationSELECTED EPIDEMIOLOGICAL ASPECTS OF SCHIZOPHRENIA: A CROSS SECTIONAL STUDY AT TERTIARY CARE HOSPITAL IN MAHARASHTRA
Original Article SELECTED EPIDEMIOLOGICAL ASPECTS OF SCHIZOPHRENIA: A CROSS SECTIONAL STUDY AT TERTIARY CARE HOSPITAL IN MAHARASHTRA Madhura D Ashturkar 1, Jaggnath V Dixit 2 Financial Support: None declared
More informationTo reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees.
E Nancy A. Haller, MPH, CHES, Manager, State Wellness Program M PLOYEES To reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees. To suspend or decrease the rising costs
More informationIs Asenapine More Effective than Other Interventions in the Treatment of Adult Patients with Bipolar I Disorder?
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2012 Is Asenapine More Effective than Other
More informationA Study to Show Postprandial Hypertriglyceridemia as a Risk Factor for Macrovascular Complications in Type 2 Diabetis Mellitus
Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2018/21 A Study to Show Postprandial Hypertriglyceridemia as a Risk Factor for Macrovascular Complications in Bingi Srinivas
More informationRunning head: PSYCHOSIS & SCHIZOPHRENIA 1. Counseling and Care of Adolescents with Psychosis & Schizophrenia. Leonard M. Williams
Running head: PSYCHOSIS & SCHIZOPHRENIA 1 The running head is a shortened version of the paper s full title, and it is used to help readers identify the titles for published articles (even if your paper
More informationDSM5: How to Understand It and How to Help
DSM5: How to Understand It and How to Help Introduction: The DSM5 is a foreign language! Three Questions: I. The first was, What the key assumptions made to determine the organization of the DSM5? A. Mental
More informationMETHODS RESULTS. Supported by funding from Ortho-McNeil Janssen Scientific Affairs, LLC
PREDICTORS OF MEDICATION ADHERENCE AMONG PATIENTS WITH SCHIZOPHRENIC DISORDERS TREATED WITH TYPICAL AND ATYPICAL ANTIPSYCHOTICS IN A LARGE STATE MEDICAID PROGRAM S.P. Lee 1 ; K. Lang 2 ; J. Jackel 2 ;
More informationHospital Resource Use by Patients with Schizophrenia: Reduction After Conversion from Oral Treatment to Risperidone Long-Acting Injection
Hospital Resource Use by Patients with Schizophrenia: Reduction After Conversion from Oral Treatment to Risperidone Long-Acting Injection David Koczerginski, MD FRCPC Larry Arshoff, MSc Study Support This
More informationType 2 diabetes in Tuvalu: A drug use and chronic disease management evaluation. Prepared for the Ministry of Health, Tuvalu.
Type 2 diabetes in Tuvalu: A drug use and chronic disease management evaluation Prepared for the Ministry of Health, Tuvalu. 2012 Investigator Alexander Bongers Intern pharmacist, Royal Melbourne Hospital,
More informationSchizophrenia. Can someone be psychotic without having schizophrenia? 11/30/2008. Name that Psychotic Disorder! Other psychotic disorders and causes
Schizophrenia Other psychotic disorders and causes Name that Psychotic Disorder! Chris has started spending large amounts of time guarding his home. They have bugged his phone and are sending cars past
More informationDiabetes Distress: The Reciprocal Relationship between Diabetes and Mental Health. Daniel J. Wachtel, Psy.D. Clinical Psychologist Geropsychologist
Diabetes Distress: The Reciprocal Relationship between Diabetes and Mental Health Daniel J. Wachtel, Psy.D. Clinical Psychologist Geropsychologist Disclosure I have no relevant financial relationships
More informationPhysical health assessment and monitoring in long-term mental health care
Physical health assessment and monitoring in long-term mental health care Dr Alan Farmer Consultant Psychiatrist Worcestershire Mental Health Partnership NHS Trust A brief questionnaire Current thoughts,
More information